These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38965978)

  • 21. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
    Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
    Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acceptability and Predictors of Uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) Among Fishing Communities in Uganda: A Cross-Sectional Discrete Choice Experiment Survey.
    Kuteesa MO; Quaife M; Biraro S; Katumba KR; Seeley J; Kamali A; Nakanjako D
    AIDS Behav; 2019 Oct; 23(10):2674-2686. PubMed ID: 30734882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP distribution in pharmacies: a systematic review.
    Kennedy CE; Yeh PT; Atkins K; Ferguson L; Baggaley R; Narasimhan M
    BMJ Open; 2022 Feb; 12(2):e054121. PubMed ID: 35190430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E; Sikkema KJ; Julies RF; Mazer K; O'Malley G; Heffron R; Morton JF; Johnson R; Celum C; Baeten JM; Bekker LG
    J Int AIDS Soc; 2024 May; 27(5):e26254. PubMed ID: 38695101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya.
    Wanga V; Omollo V; Bukusi EA; Odoyo JB; Morton JF; Kidoguchi L; Johnson R; Hughes JP; Celum C; Baeten JM
    J Int AIDS Soc; 2020 Aug; 23(8):e25561. PubMed ID: 32820597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment.
    Lancaster KE; Lungu T; Bula A; Shea JM; Shoben A; Hosseinipour MC; Kohler RE; Hoffman IF; Go VF; Golin CE; Wheeler SB; Miller WC
    AIDS Behav; 2020 May; 24(5):1294-1303. PubMed ID: 31720955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.
    Dubov A; Ogunbajo A; Altice FL; Fraenkel L
    AIDS Care; 2019 May; 31(5):545-553. PubMed ID: 30554519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection.
    Vickerman P; Quaife M; Kilbourne-Brook M; Mvundura M; Eakle R; Terris-Prestholt F
    BMC Infect Dis; 2020 Sep; 20(1):704. PubMed ID: 32977745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study.
    Kabami J; Kakande E; Chamie G; Balzer LB; Petersen ML; Camlin CS; Nyabuti M; Koss CA; Bukusi EA; Kamya MR; Havlir DV; Ayieko J
    J Int AIDS Soc; 2023 Jul; 26 Suppl 1(Suppl 1):e26121. PubMed ID: 37408473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliciting women's preferences for place of child birth at a peri-urban setting in Nairobi, Kenya: A discrete choice experiment.
    Oluoch-Aridi J; Adam MB; Wafula F; K'okwaro G
    PLoS One; 2020; 15(12):e0242149. PubMed ID: 33301447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A community-based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial.
    Kakande ER; Ayieko J; Sunday H; Biira E; Nyabuti M; Agengo G; Kabami J; Aoko C; Atuhaire HN; Sang N; Owaranganise A; Litunya J; Mugoma EW; Chamie G; Peng J; Schrom J; Bacon MC; Kamya MR; Havlir DV; Petersen ML; Balzer LB;
    J Int AIDS Soc; 2023 Dec; 26(12):e26195. PubMed ID: 38054535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa.
    Quaife M; Eakle R; Cabrera Escobar MA; Vickerman P; Kilbourne-Brook M; Mvundura M; Delany-Moretlwe S; Terris-Prestholt F
    Med Decis Making; 2018 Jan; 38(1):120-133. PubMed ID: 28863752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya.
    Dettinger JC; Kinuthia J; Pintye J; Abuna F; Begnel E; Mugwanya K; Sila J; Lagat H; Baeten JM; John-Stewart G
    J Int AIDS Soc; 2019 Sep; 22(9):e25378. PubMed ID: 31498563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya.
    Wara NJ; Mvududu R; Marwa MM; Gómez L; Mashele N; Orrell C; Moucheraud C; Kinuthia J; John-Stewart G; Myer L; Hoffman R; Pintye J; Davey DLJ
    J Int AIDS Soc; 2023 May; 26(5):e26088. PubMed ID: 37221983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation preferences for the management of sexually transmitted infections in the South African health system: a discrete choice experiment.
    Iwuji C; Martin CE; Pillay D; Shamu P; Nzenze S; Murire M; Cox LA; Miners A; Llewellyn C; Mullick S
    Sex Transm Infect; 2024 Jan; 100(1):10-16. PubMed ID: 37918916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation strategies for integrating pre-exposure prophylaxis for HIV prevention and family planning services for adolescent girls and young women in Kenya: a qualitative study.
    Roche SD; Barnabee G; Omollo V; Mogaka F; Odoyo J; Bukusi EA; Morton JF; Johnson R; Celum C; Baeten JM; O'Malley G
    BMC Health Serv Res; 2022 Mar; 22(1):422. PubMed ID: 35354456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.
    Seidman D; Carlson K; Weber S; Witt J; Kelly PJ
    Contraception; 2016 May; 93(5):463-9. PubMed ID: 26772906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.
    Luecke EH; Cheng H; Woeber K; Nakyanzi T; Mudekunye-Mahaka IC; van der Straten A;
    J Int AIDS Soc; 2016; 19(1):20875. PubMed ID: 27247202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.